Evidence map›Paper›PMID 40011712›Full record

ArticleNature chemistry2025

A glycan foldamer that uses carbohydrate-aromatic interactions to perform catalysis.

Kaimeng Liu, Martina Delbianco

Abstract read
In one paragraph

Article in Nature chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Dual Photo- and pH-Responsive Foldamer Metallogels.Journal of the American Chemical Society · 2026
    Article
  2. Article
  3. Glycosaminoglycans as Polyelectrolytes: Charge, Interactions, and Applications.Chembiochem : a European journal of chemical biology · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kaimeng LiuDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.ORCID 0000-0002-7346-1022
Martina DelbiancoDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany. martina.delbianco@mpikg.mpg.de.ORCID 0000-0002-4580-9597

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 13XP5114EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101075357-GLYCOFOLD
6 · The paper itself

Abstract

In nature, the ability to catalyse reactions is primarily associated with proteins and ribozymes. Inspired by these systems, peptide-based catalysts have been designed to accelerate chemical reactions and/or ensure regio- and stereoselective transformations. We wondered whether other biomolecules (such as glycans) could be designed to perform catalytic functions, expanding the portfolio of synthetic functional oligomers. Here we report a glycan foldamer inspired by the natural Sialyl Lewis X antigen that acts as catalyst in a chemical reaction. This glycan-based catalyst benefits from structural rigidity and modular adaptability, incorporating a substrate-recognition motif alongside a catalytic active site. Leveraging the inherent ability of carbohydrates to engage in CH-π interactions with aromatic substrates, we demonstrate the recruitment and functionalization of a tryptophan via a Pictet-Spengler transformation. Our modular glycan catalyst accelerates the reaction kinetics, enabling the modification of tryptophan-containing peptides in aqueous environments. Our findings pave the way for the development of glycan-based catalysts and suggest the possibility of catalytic capabilities of glycans in biological contexts.

Indexed as

PolysaccharidesCatalysisCatalytic DomainKineticsModels, MolecularSialyl Lewis X AntigenTryptophanPolysaccharidesSialyl Lewis X AntigenTryptophan

Identifiers

PMID40011712
PMCPMC12141037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.